82 FR 13354 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 46 (March 10, 2017)

Page Range		13354-13354
FR Document		2017-04709

Federal Register, Volume 82 Issue 46 (Friday, March 10, 2017)

[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Page 13354]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04709]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Phase 1 and Phase 11, Bioreactors for 
Reparative Medicine (STTR).
    Date: March 30, 2017.
    Time: 2:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, Room 
7180, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Phase 1 and Phase 11, Bioreactors for 
Reparative Medicine (SBIR).
    Date: March 30, 2017.
    Time: 2:30 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, Room 
7180, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; SBIR Direct Phase II, Bioreactors for 
Reparative Medicine.
    Date: March 30, 2017.
    Time: 3:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, Room 
7180, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Tony L. Creazzo, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 
20892-7924, 301-435-0725, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: March 6, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04709 Filed 3-9-17; 8:45 am]
BILLING CODE 4140-01-P

13354 Federal Register / Vol. 82, No. 46 / Friday, March 10, 2017 / Notices

Dated: March 6, 2017. Agenda: To review and evaluate grant Time: 11:30 a.m. to 1:00 p.m.
Sylvia L. Neal, applications. Agenda: To review and evaluate grant
Program Analyst, Office of Federal Advisory Place: National Institutes of Health, 6701 applications.
Rockledge Drive, Room 7180, Bethesda, MD Place: The William F. Bolger Center, 9600
Committee Policy.
20892 (Telephone Conference Call). Newbridge Drive, Potomac, MD 20854.
[FR Doc. 2017–04710 Filed 3–9–17; 8:45 am] Contact Person: Tony L. Creazzo, Ph.D., Contact Person: Michael P. Reilly, Ph.D.,
BILLING CODE 4140–01–P Scientific Review Officer, Office of Scientific Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room Blood Institute, 6701 Rockledge Drive, Room
DEPARTMENT OF HEALTH AND 7180, Bethesda, MD 20892–7924, 301–435– 7200, Bethesda, MD 20892, 301–827–7975,
HUMAN SERVICES 0725, creazzotl@mail.nih.gov. reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance
National Institutes of Health Program Nos. 93.233, National Center for Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and Sleep Disorders Research; 93.837, Heart and
National Heart, Lung, and Blood Vascular Diseases Research; 93.838, Lung Vascular Diseases Research; 93.838, Lung
Institute; Notice of Closed Meetings Diseases Research; 93.839, Blood Diseases Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes and Resources Research, National Institutes
Pursuant to section 10(d) of the of Health, HHS) of Health, HHS)
Federal Advisory Committee Act, as
Dated: March 6, 2017. Dated: March 6, 2017.
amended (5 U.S.C. App.), notice is
Michelle Trout, Michelle Trout,
hereby given of the following meetings.
The meetings will be closed to the Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory
public in accordance with the Committee Policy. Committee Policy.
provisions set forth in sections [FR Doc. 2017–04709 Filed 3–9–17; 8:45 am] [FR Doc. 2017–04708 Filed 3–9–17; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., BILLING CODE 4140–01–P BILLING CODE 4140–01–P
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
property such as patentable material, HUMAN SERVICES HUMAN SERVICES
and personal information concerning
National Institutes of Health National Institutes of Health
individuals associated with the grant
applications, the disclosure of which National Heart, Lung, and Blood National Heart, Lung, and Blood
would constitute a clearly unwarranted Institute; Notice of Closed Meetings Institute; Notice of Closed Meeting
invasion of personal privacy.
Pursuant to section 10(d) of the Pursuant to section 10(d) of the
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel; Federal Advisory Committee Act, as Federal Advisory Committee Act, as
Phase 1 and Phase 11, Bioreactors for amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is
Reparative Medicine (STTR). hereby given of the following meetings. hereby given of the following meetings.
Date: March 30, 2017. The meetings will be closed to the The meetings will be closed to the
Time: 2:00 p.m. to 2:30 p.m. public in accordance with the public in accordance with the
Agenda: To review and evaluate grant provisions set forth in sections provisions set forth in sections
applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Place: National Institutes of Health, 6701
as amended. The grant applications and as amended. The grant applications and
Rockledge Drive, Room 7180, Bethesda, MD
20892 (Telephone Conference Call). the discussions could disclose the discussions could disclose
Contact Person: Tony L. Creazzo, Ph.D., confidential trade secrets or commercial confidential trade secrets or commercial
Scientific Review Officer, Office of Scientific property such as patentable material, property such as patentable material,
Review/DERA, National Heart, Lung, and and personal information concerning and personal information concerning
Blood Institute, 6701 Rockledge Drive, Room individuals associated with the grant individuals associated with the grant
7180, Bethesda, MD 20892–7924, 301–435– applications, the disclosure of which applications, the disclosure of which
0725, creazzotl@mail.nih.gov. would constitute a clearly unwarranted would constitute a clearly unwarranted
Name of Committee: National Heart, Lung, invasion of personal privacy. invasion of personal privacy.
and Blood Institute Special Emphasis Panel;
Phase 1 and Phase 11, Bioreactors for Name of Committee: National Heart, Lung, Name of Committee: National Heart, Lung,
Reparative Medicine (SBIR). and Blood Institute Special Emphasis Panel; and Blood Institute Special Emphasis Panel;
Date: March 30, 2017. Onsite Tools and Technology. Clinical Trials of Transplants for Blood
Time: 2:30 p.m. to 3:00 p.m. Date: March 30, 2017. Diseases.
Agenda: To review and evaluate grant Time: 11:00 a.m. to 2:00 p.m. Date: March 30–31, 2017.
applications. Agenda: To review and evaluate grant Time: 8:00 a.m. to 11:00 a.m.
Place: National Institutes of Health, 6701 applications. Agenda: To review and evaluate grant
Rockledge Drive, Room 7180, Bethesda, MD Place: National Institutes of Health, 6701 applications.
20892 (Telephone Conference Call). Rockledge Drive, Room 7198, Bethesda, MD Place: The William F. Bolger Center, 9600
Contact Person: Tony L. Creazzo, Ph.D., 20892 (Telephone Conference Call). Newbridge Drive, Potomac, MD 20854.
Scientific Review Officer, Office of Scientific Contact Person: Kristin Goltry, Ph.D., Contact Person: Michael P. Reilly, Ph.D.,
Review/DERA, National Heart, Lung, and Scientific Review Officer, Office of Scientific Scientific Review Officer, Office of Scientific
Blood Institute, 6701 Rockledge Drive, Room Review/DERA, National Heart, Lung, and Review/DERA, National Heart, Lung, and
sradovich on DSK3GMQ082PROD with NOTICES

7180, Bethesda, MD 20892–7924, 301–435– Blood Institute, 6701 Rockledge Drive, Room Blood Institute, 6701 Rockledge Drive, Room
0725, creazzotl@mail.nih.gov. 7198, Bethesda, MD 20892, 301–435–0297, 7200, Bethesda, MD 20892, 301–827–7975,
Name of Committee: National Heart, Lung, goltrykl@mail.nih.gov. reillymp@nhlbi.nih.gov.
and Blood Institute Special Emphasis Panel; Name of Committee: National Heart, Lung, Name of Committee: National Heart, Lung,
SBIR Direct Phase II, Bioreactors for and Blood Institute Special Emphasis Panel; and Blood Institute Special Emphasis Panel;
Reparative Medicine. Data Center for Clinical Trials of Transplants Translational Programs in Lung Diseases.
Date: March 30, 2017. for Blood Diseases. Date: March 30–31, 2017.
Time: 3:00 p.m. to 4:00 p.m. Date: March 31, 2017. Time: 12:30 p.m. to 3:00 p.m.

VerDate Sep<11>2014 18:37 Mar 09, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\10MRN1.SGM 10MRN1

Document Created: 2018-02-01 14:52:57
Document Modified: 2018-02-01 14:52:57

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 30, 2017.
FR Citation		82 FR 13354

82 FR 13354 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 46 (March 10, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health